AAC
FEATURE
Suzanne Kellar McCarty, whose son died of a fen- tanyl overdose, shares her personal story. Par- ent Teacher Association President-Elect Melinda Kinnison, right, listens.
Above: Arkansas Drug Director Kirk Lane. Far Left: Mack Hutchi- son, Quality Assurance Manager for Metropolitan Emergency Man- agement Services. Left middle: Sheila Thrower, Little Rock Central High School nurse. Left: Jim Tom Bell with Quapaw House.
U.S. Congressman Hill holds opioid conference Panelists suggest more rehabilitation choices, education to fight opioid crisis
Story and Photos by Holland doran AAC Communications Coordinator
Stories in Central Arkansas” meeting June 18. Te event was hosted by U.S. Rep. French Hill at the
S 30
University of Arkansas at Little Rock. Te panel discussion was moderated by Arkansas Surgeon
General Dr. Greg Bledsoe, who offered his expertise on treating opioid addiction: “It’s a disease and you have to treat it as a disease.” Rep. Hill opened the meeting by welcoming attendees, and also took part in the panel discussion by answering questions regarding the U.S. Congressional efforts to produce legislation to combat the opioid crisis. Hill said the House of Representatives passed more than 36 bills covering a range of issues, including law enforcement, criminal justice, and addiction prevention and treatment. Arkansas Drug Director Kirk Lane expressed the urgency
Above: CDR Karen Hearod, Substance Abuse and Mental Health Services Administration Regional Administrator, U.S. Congressman French Hill and Arkansas Surgeon General Dr. Greg Bledsoe chat before the meeting.
to develop solutions to end the epidemic, and stressed that the biggest obstacle to combating the problem in Arkansas is “adapting to change.” Lane also shared the successes of programs such as the
Arkansas Take Back program that has been the most successful program of its kind in the country.
COUNTY LINES, SUMMER 2018
olutions to the opioid epidemic plaguing Arkansas was one of the topics a panel of eight people across a variety of fields discussed at the “Opioids in Our Community: Resources and
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68